Axxam SPA

We are a leading provider of integrated discovery across Life Sciences industries with a major focus on pharmaceuticals, and with access to novel modalities such as VHH/nanobodies.

We have consolidated expertise across a broad range of discovery disciplines and innovative technologies including biophysical, biochemical and cell-based assay development, high-content image-based screening, electrophysiology on whole cells and on isolated organelles, in vitro disease modelling, including use of recombinant and patient-derived iPSC cells, virtual, synthetic and natural compound collections, high-throughput screening (HTS) and compound profiling, hit identification, validation, and medicinal chemistry-assisted hit-to-lead and lead optimization